Thursday, June 7, 2018

Oncogene - Table of Contents alert Volume 37 Issue 23

If you are unable to see the message below, click here to view.
Oncogene

TABLE OF CONTENTS

Volume 37, Issue 23

In this issue
Review Article
Article
Also new
AOP

Advertisement
Nature Outlook: Cancer immunotherapy 

Drugs that mobilize our immune systems against cancer are dramatically improving care for many people, and research is rapidly moving ahead in the lab and the clinic. 

Access this Outlook free >> 

Produced with support from 
F. Hoffmann-La Roche Ltd  
Medimmune 

Produced with support of a grant from Merck & Co., Inc.

Review Article

Controlling the master—upstream regulation of the tumor suppressor LKB1

Lars Kullmann & Michael P. Krahn

Oncogene 2018 37 :3045 - 3057; March 15, 2018; 10.1038/s41388-018-0145-z

Abstract | Full Text

Off and back-on again: a tumor suppressor's tale

Jonuelle Acosta, Walter Wang & David M. Feldser

Oncogene 2018 37 :3058 - 3069; March 15, 2018; 10.1038/s41388-018-0186-3

Abstract | Full Text

Article

Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway

Peng Jin, Seung-Hyun Shin, Yang-Sook Chun, Hyun-Woo Shin, Yong Jae Shin et al.

Oncogene 2018 37 :3070 - 3087; March 14, 2018; 10.1038/s41388-018-0182-7

Abstract | Full Text

JNK and Yorkie drive tumor progression by generating polyploid giant cells in Drosophila

Bojie Cong, Shizue Ohsawa & Tatsushi Igaki

Oncogene 2018 37 :3088 - 3097; March 14, 2018; 10.1038/s41388-018-0201-8

Abstract | Full Text

LncFZD6 initiates Wnt/ß-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation

Zhenzhen Chen, Yanfeng Gao, Lintong Yao, Yating Liu, Lan Huang et al.

Oncogene 2018 37 :3098 - 3112; March 14, 2018; 10.1038/s41388-018-0203-6

Abstract | Full Text

LMTK3 confers chemo-resistance in breast cancer

Justin Stebbing, Kalpit Shah, Lei Cheng Lit, Teresa Gagliano, Angeliki Ditsiou et al.

Oncogene 2018 37 :3113 - 3130; March 15, 2018; 10.1038/s41388-018-0197-0

Abstract | Full Text

FES-related tyrosine kinase activates the insulin-like growth factor-1 receptor at sites of cell adhesion

Joanna Stanicka, Leonie Rieger, Sandra O'Shea, Orla Cox, Michael Coleman et al.

Oncogene 2018 37 :3131 - 3150; March 15, 2018; 10.1038/s41388-017-0113-z

Abstract | Full Text

miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy

Jiajia Xi, Qian Huang, Lei Wang, Xiaodong Ma, Qipan Deng et al.

Oncogene 2018 37 :3151 - 3165; March 15, 2018; 10.1038/s41388-018-0178-3

Abstract | Full Text

Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing

Zsofia Miskolczi, Michael P. Smith, Emily J. Rowling, Jennifer Ferguson, Jorge Barriuso et al.

Oncogene 2018 37 :3166 - 3182; March 16, 2018; 10.1038/s41388-018-0209-0

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: